Company: DHR
Filing Date: 2025-07-22
Form Type: 10-Q
Source: 0000313616-25-000153
Chunk: 152

Company: DANAHER CORP /DE/
Filing Date: 2025-07-22
Form: 10-Q
Item: Item 2
Chunk 152
---
, the Company anticipates following the same approach in the future.

Overview of Cash Flows and Liquidity

Following is an overview of the Company’s cash flows and liquidity ($ in millions):

Six-Month Period EndedJune 27, 2025June 28, 2024Net cash provided by operating activities$2,637 $3,156 Cash paid for acquisitions$— $(12)Payments for additions to property, plant and equipment(493)(578)Proceeds from sales of property, plant and equipment10 1 Payments for purchases of investments(50)(127)Proceeds from sales of investments10 9 Proceeds from sale of product line9 — All other investing activities14 26 Total cash used in investing activities$(500)$(681)Proceeds from the issuance of common stock in connection with stock-based compensation, net$14 $76 Payment of dividends(423)(377)Net borrowings (maturities longer than 90 days)4 — Net (repayments of) proceeds from borrowings (maturities of 90 days or less)(1)15 Net repayments of borrowings (maturities longer than 90 days)— (974)Payments for repurchase of common stock (1,078)(4,530)All other financing activities(18)(58)Total cash used in financing activities$(1,502)$(5,848)

As of June 27, 2025, the Company held approximately $3.0 billion of cash and cash equivalents.

Operating Activities

Cash flows from operating activities can fluctuate significantly from period-to-period as working capital needs and the timing of payments for income taxes, restructuring activities and productivity improvement initiatives and other items impact reported cash flows.

35

Operating cash flows were approximately $2.6 billion for the first six months of 2025, a decrease of $519 million, or 16%, as compared to the comparable period of 2024.  The year-over-year change in operating cash flows from 2024 to 2025 was primarily attributable to the following factors:

•2025 operating cash flows reflected a decrease of $486 million in net earnings for the first six months of 2025 as compared to the comparable period in 2024.  

•Net earnings for the first six months of 2025 also included $492 million higher year-over-year noncash charges primarily for impairments, as well as for unrealized investment gains/losses,